Blood Advances · 2017 · 34 citations · 54 references
Life SciencesGeneticsHematologyGene ExpressionOncogenesStem Cell BiologyHematopoietic DevelopmentHematopoietic NeoplasmsHematopoietic Stem Cell BiologyHematopoietic Stem CellsMyeloproliferative NeoplasmsPolycomb Regulation3' Untranslated Region RegulationAdult Hematopoietic Stem CellsCellular OncogenesFetal Hematopoietic Stem CellsHematopoietic Stem Cell Transcriptional RegulationJak2 V617f MutationPolycomb Repressive Complex 2Polycomb-mediated Repression
Key Points In patients with MPNs, repression of MIRlet-7 and mutations in the polycomb genes EZH2 and ASXL1 correlate with HMGA2 overexpression. Hmga2 overexpression collaborates with JAK2V617F to promote lethal MPN in mice, highlighting the crucial role of Hmga2.
54
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
Chloé James, Valérie Ugo, Jean‐Pierre Le Couedic et al. · Nature · 2005 · 3.5K citations
A Gain-of-Function Mutation of <i>JAK2</i> in Myeloproliferative Disorders
Róbert Královics, Francesco Passamonti, Andreas Buser et al. · New England Journal of Medicine · 2005 · 3.5K citations · Full text
Life Sciences, Genetics, Hematology +15
Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms
Thorsten Klampfl, Heinz Gisslinger, Ashot S. Harutyunyan et al. · New England Journal of Medicine · 2013 · 2K citations · Full text
Medicine, Genetics, Hematology +14
Mutation in <i>TET2</i> in Myeloid Cancers
François Delhommeau, Sabrina Dupont, Véronique Della Valle et al. · New England Journal of Medicine · 2009 · 1.7K citations · Full text